Literature DB >> 11466140

Perception and documentation of arrhythmias after successful radiofrequency catheter ablation of accessory pathways.

H Oddsson1, H Walfridsson, N Edvardsson.   

Abstract

BACKGROUND: Some patients continue to have palpitations in spite of successful ablation of Wolff-Parkinson-White (WPW) syndrome. Recurrence of accessory pathways as well as unrelated arrhythmias may explain the symptoms.
METHODS: We followed 194 consecutive patients after successful radiofrequency catheter ablation of overt (147) or concealed (47) WPW syndrome. The mean duration of symptoms was 16 +/- 13 years. Atrial fibrillation was documented in 54 patients (24%) prior to ablation. 185 patients responded to a questionnaire 24 +/- 12 months after ablation.
RESULTS: The physical well-being was improved in 94%, unchanged in 5%, and deteriorated in 1%. However, 76 patients (39%) reported arrhythmia symptoms, in 40 patients causing pharmacological treatment (14 patients) and/or continued contact with their doctor. The underlying arrhythmias were orthodromic tachycardia (10), atrial fibrillation (12), premature beats (12), atrial flutter (1), and ventricular tachycardia (1), while in four patients no explanation was found. Minor symptoms in the other 36 patients were explained by premature beats in 29, while unexplained in 7. All patients with atrial fibrillation after ablation had atrial fibrillation before ablation. Ten relapses of WPW syndrome occurred: eight were known before the time of the questionnaire, two were confirmed at transesophageal atrial stimulation.
CONCLUSION: 94% patients with a long history of tachyarrhythmias due to the WPW syndrome reported improved physical well-being after ablation, but palpitations were common during a 2-year follow-up period; 8% continued to use pharmacological antiarrhythmic treatment. Five percent had symptomatic relapses and in 6% atrial fibrillation episodes reoccurred, i.e., in half of those who had atrial fibrillation before ablation.

Entities:  

Mesh:

Year:  2001        PMID: 11466140      PMCID: PMC7027629          DOI: 10.1111/j.1542-474x.2001.tb00111.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  10 in total

1.  Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current.

Authors:  W M Jackman; X Z Wang; K J Friday; C A Roman; K P Moulton; K J Beckman; J H McClelland; N Twidale; H A Hazlitt; M I Prior
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

2.  Frequency of disabling symptoms in supraventricular tachycardia.

Authors:  K A Wood; B J Drew; M M Scheinman
Journal:  Am J Cardiol       Date:  1997-01-15       Impact factor: 2.778

3.  Radiofrequency current catheter ablation of accessory atrioventricular pathways.

Authors:  K H Kuck; M Schlüter; M Geiger; J Siebels; W Duckeck
Journal:  Lancet       Date:  1991-06-29       Impact factor: 79.321

4.  Usefulness of follow-up electrophysiologic study and event monitoring after successful radiofrequency catheter ablation of supraventricular tachycardia. Atakr Multicenter Investigators Group.

Authors:  A B Wagshal; L A Pires; P G Yong; S A Moser; F Mazzola; R S Mittleman; S K Huang
Journal:  Am J Cardiol       Date:  1995-01-01       Impact factor: 2.778

5.  New observations on atrial fibrillation before and after surgical treatment in patients with the Wolff-Parkinson-White syndrome.

Authors:  P S Chen; J C Pressley; A S Tang; D L Packer; J J Gallagher; E N Prystowsky
Journal:  J Am Coll Cardiol       Date:  1992-04       Impact factor: 24.094

6.  Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome.

Authors:  H Calkins; J Langberg; J Sousa; R el-Atassi; A Leon; W Kou; S Kalbfleisch; F Morady
Journal:  Circulation       Date:  1992-04       Impact factor: 29.690

7.  Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias.

Authors:  R S Bubien; S M Knotts-Dolson; V J Plumb; G N Kay
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

8.  Ventricular fibrillation in the Wolff-Parkinson-White syndrome.

Authors:  G J Klein; T M Bashore; T D Sellers; E L Pritchett; W M Smith; J J Gallagher
Journal:  N Engl J Med       Date:  1979-11-15       Impact factor: 91.245

9.  Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways.

Authors:  M Haissaguerre; B Fischer; T Labbé; P Lemétayer; P Montserrat; C d'Ivernois; J F Dartigues; J F Warin
Journal:  Am J Cardiol       Date:  1992-02-15       Impact factor: 2.778

10.  Paroxysmal atrial fibrillation in the Wolff-Parkinson-White syndrome.

Authors:  R A Bauernfeind; C R Wyndham; S P Swiryn; E V Palileo; B Strasberg; W Lam; D Westveer; K M Rosen
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

  10 in total
  1 in total

1.  Symptomatic improvement after catheter ablation of supraventricular tachycardia measured by the arrhythmia-specific questionnaire U22.

Authors:  Milos Kesek; Folke Rönn; Titti Tollefsen; Niklas Höglund; Ulf Näslund; Steen M Jensen
Journal:  Ups J Med Sci       Date:  2010-11-16       Impact factor: 2.384

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.